Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry-Johnson and Johnson and Pfizer, Incorporated ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) Assets: Cash Short-term investments Accounts receivable (net) Inventory Other current assets Current assets Property, plant, and equipment (net) Intangibles and other assets Total assets Liabilities and Shareholders' Equity: Accounts payable Short-term notes Other current liabilities Current liabilities Long-term debt Other long-term liabilities Total liabilities Common stock (par and additional paid-in capital) Retained earnings Accumulated other comprehensive income (loss) Less: Treasury stock and other equity adjustments Total shareholders' equity Total liabilities and shareholders' equity Net sales Johnson and Johnson Pfizer $ 17,305 $ 1,305 1,982 8,525 14,481 8,724 9,020 8,283 2,486 5,966 45,274 32,803 17,658 13,967 94,796 120,719 $ 157,728 $ 167,489 $ 8,544 $ 4,220 1,202 16,195 26,218 16,889 35,964 37,304 26,494 35,955 35,799 30,783 98,257 104,042 3,120 87,896 110,659 97,670 (11,640) (15,891) (38,417) 59,471 (110,479) 63,447 $ 167,489 $ 157,728 Income Statements $ 82,059 $ 51,750